Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC500115226;15227;15228 chr2:178734923;178734922;178734921chr2:179599650;179599649;179599648
N2AB468414275;14276;14277 chr2:178734923;178734922;178734921chr2:179599650;179599649;179599648
N2A375711494;11495;11496 chr2:178734923;178734922;178734921chr2:179599650;179599649;179599648
N2BNoneNone chr2:Nonechr2:None
Novex-1NoneNone chr2:Nonechr2:None
Novex-2NoneNone chr2:Nonechr2:None
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: L
  • RefSeq wild type transcript codon: CTC
  • RefSeq wild type template codon: GAG
  • Domain: Ig-33
  • Domain position: 21
  • Structural Position: 30
  • Q(SASA): 0.25
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
L/F None None 0.999 N 0.801 0.386 0.567678221081 gnomAD-4.0.0 4.78956E-06 None None None None N None 0 0 None 0 0 None 0 0 8.60072E-06 0 0
L/V rs774593495 -1.294 0.992 D 0.701 0.54 0.68230992181 gnomAD-2.1.1 4.11E-06 None None None None N None 0 0 None 0 0 None 0 None 0 9.15E-06 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
L/A 0.9408 likely_pathogenic 0.9521 pathogenic -2.578 Highly Destabilizing 0.997 D 0.767 deleterious None None None None N
L/C 0.9186 likely_pathogenic 0.9332 pathogenic -1.754 Destabilizing 1.0 D 0.777 deleterious None None None None N
L/D 0.9989 likely_pathogenic 0.9988 pathogenic -3.281 Highly Destabilizing 1.0 D 0.843 deleterious None None None None N
L/E 0.9916 likely_pathogenic 0.9921 pathogenic -3.004 Highly Destabilizing 1.0 D 0.845 deleterious None None None None N
L/F 0.1578 likely_benign 0.237 benign -1.693 Destabilizing 0.999 D 0.801 deleterious N 0.508756336 None None N
L/G 0.9855 likely_pathogenic 0.9868 pathogenic -3.114 Highly Destabilizing 1.0 D 0.839 deleterious None None None None N
L/H 0.9457 likely_pathogenic 0.955 pathogenic -2.644 Highly Destabilizing 1.0 D 0.823 deleterious D 0.815585471 None None N
L/I 0.1599 likely_benign 0.1913 benign -0.98 Destabilizing 0.992 D 0.691 prob.neutral D 0.589167828 None None N
L/K 0.9832 likely_pathogenic 0.984 pathogenic -2.024 Highly Destabilizing 1.0 D 0.853 deleterious None None None None N
L/M 0.2112 likely_benign 0.2582 benign -0.94 Destabilizing 0.985 D 0.632 neutral None None None None N
L/N 0.9917 likely_pathogenic 0.9926 pathogenic -2.583 Highly Destabilizing 1.0 D 0.839 deleterious None None None None N
L/P 0.9954 likely_pathogenic 0.9948 pathogenic -1.502 Destabilizing 1.0 D 0.837 deleterious D 0.815585471 None None N
L/Q 0.9449 likely_pathogenic 0.9528 pathogenic -2.36 Highly Destabilizing 1.0 D 0.829 deleterious None None None None N
L/R 0.9635 likely_pathogenic 0.9642 pathogenic -1.941 Destabilizing 0.999 D 0.841 deleterious D 0.815585471 None None N
L/S 0.9847 likely_pathogenic 0.9878 pathogenic -3.153 Highly Destabilizing 1.0 D 0.856 deleterious None None None None N
L/T 0.9653 likely_pathogenic 0.9737 pathogenic -2.724 Highly Destabilizing 1.0 D 0.827 deleterious None None None None N
L/V 0.2538 likely_benign 0.3087 benign -1.502 Destabilizing 0.992 D 0.701 prob.neutral D 0.690848973 None None N
L/W 0.7024 likely_pathogenic 0.772 pathogenic -2.07 Highly Destabilizing 1.0 D 0.789 deleterious None None None None N
L/Y 0.7302 likely_pathogenic 0.7906 pathogenic -1.786 Destabilizing 1.0 D 0.797 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.